Opportunistic Pathogens Citation List: November 27 – December 10, 2008

Opportunistic protozoa (pneumocystis, cryptosporidium, toxoplasma, microsporidia [encephalitozoon, enterocytozoon, vittaforma)          

1. Anti-toxoplasmosis Effects of Oleuropein Isolated from Fraxinus rhychophylla.

Jiang JH, Jin CM, Kim YC, Kim HS, Park WC, Park H.

Biol Pharm Bull. 2008 Dec;31(12):2273-6.

PMID: 19043212          

2. Inhibition of Toxoplasma gondii by indirubin and tryptanthrin analogs.

Krivogorsky B, Grundt P, Yolken R, Jones-Brando L.

Antimicrob Agents Chemother. 2008 Dec;52(12):4466-9. Epub 2008 Sep 29.

PMID: 18824607 [PubMed - in process]            

3. Lanostane-Type Triterpenes from the Mushroom Astraeus pteridis with Antituberculosis Activity.

Stanikunaite R, Radwan MM, Trappe JM, Fronczek F, Ross SA.

J Nat Prod. 2008 Dec 9. [Epub ahead of print]

PMID: 19067555 [PubMed - as supplied by publisher]    

4. Knowledge Based Identification of Potent Antitubercular Compounds Using Structure Based Virtual Screening and Structure Interaction Fingerprints.

Kumar A, Chaturvedi V, Bhatnagar S, Sinha S, Siddiqi MI.

J Chem Inf Model. 2008 Dec 9. [Epub ahead of print]

PMID: 19063713 [PubMed - as supplied by publisher]    

5. Highly active potential antituberculotics: 3-(4-alkylphenyl)-4-thioxo-2H-1,3-benzoxazine-2(3H)-ones and 3-(4-alkylphenyl)-2H-1,3-benzoxazine-2,4(3H)-dihiones substituted in ring-B by halogen.

Waisser K, Matyk J, Kunes J, Dolezal R, Kaustová J, Dahse HM.

Arch Pharm (Weinheim). 2008 Dec;341(12):800-3.

PMID: 19006090 [PubMed - in process]

6. Clubbed [1,2,3] triazoles by fluorine benzimidazole: a novel approach to H37Rv inhibitors as a potential treatment for tuberculosis.

Gill C, Jadhav G, Shaikh M, Kale R, Ghawalkar A, Nagargoje D, Shiradkar M.

Bioorg Med Chem Lett. 2008 Dec 1;18(23):6244-7. Epub 2008 Oct 2.

PMID: 18930654 [PubMed - in process]            

7. Synthetic chalcones as efficient inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase PtpA.

Chiaradia LD, Mascarello A, Purificação M, Vernal J, Cordeiro MN, Zenteno ME, Villarino A, Nunes RJ, Yunes RA, Terenzi H.

Bioorg Med Chem Lett. 2008 Dec 1;18(23):6227-30. Epub 2008 Oct 5.

PMID: 18930396 [PubMed - in process]            

8. Synthesis of Arabino glycosyl triazoles as potential inhibitors of mycobacterial cell wall biosynthesis.

Wilkinson BL, Long H, Sim E, Fairbanks AJ.

Bioorg Med Chem Lett. 2008 Dec 1;18(23):6265-7. Epub 2008 Sep 26.

PMID: 18926698 [PubMed - in process]            

9. In vivo efficacy and pharmacokinetics of tomopenem (CS-023), a novel carbapenem, against Pseudomonas aeruginosa in a murine chronic respiratory tract infection model.

Morinaga Y, Yanagihara K, Nakamura S, Yamamoto K, Izumikawa K, Seki M, Kakeya H, Yamamoto Y, Yamada Y, Kohno S, Kamihira S.

J Antimicrob Chemother. 2008 Dec;62(6):1326-31. Epub 2008 Oct 3.

PMID: 18835805 [PubMed - in process]            

Antimicrobials, Antifungals (General)

10. Antimicrobial anthraquinones from Morinda angustifolia.

Xiang W, Song QS, Zhang HJ, Guo SP.

Fitoterapia. 2008 Dec;79(7-8):501-504. Epub 2008 Jun 22.

PMID: 18621113 [PubMed - as supplied by publisher]